Printer Friendly

Many may not need vitamin D supplements.

Vitamin D levels above 20 ng/mL were not associated with lower mortality rates in patients with and without kidney disease; however, levels below 12 ng/mL were associated with higher mortality rates in these patients, according to the results of an observational study.

The minimal difference in mortality rates for individuals with vitamin D levels between 20 ng/mL and 30 ng/mL suggests that vitamin D supplements may not be necessary for approximately 3 million adults with chronic kidney disease and 75 million adults without kidney disease, said Dr. Holly Kramer, who is with Loyola University Medical Center in Maywood, Ill., and her colleagues.

To examine the impact of vitamin D levels on mortality, the researchers reviewed data from 15,099 adults who were part of the Third National Health and Nutrition Examination Study (NHANES III).

The study population included 1,097 adults with chronic kidney disease, which was defined as an estimated glomerular filtration rate of less than 60 mL/min per 1.73 [m.sup.2].

In order for mortality rates to be compared, the researchers divided the study population into groups based on vitamin D levels, ranging from less than 12 ng/mL to greater than 40 ng/mL, using the 24- to 29.9-ng/mL group as the reference group.

"This group was selected as the referent, because it includes 25[OH]D levels which are above the threshold for "risk of insufficiency,' defined by the Institute of Medicine Committee to Review Dietary Reference Intakes for Vitamin D and Calcium, yet below the thresholds defined as 'insufficient" in previous analyses," Dr. Kramer and her associates wrote.

Overall, about one-third of the adults with kidney disease (35%) and of those without kidney disease (30%) had insufficient levels of vitamin D, based on recommendations from the Institute of Medicine.

The median vitamin D levels for each of the groups were 10.0 ng/mL, 14.1 ng/mL, 18.0 ng/mL, 21.9 ng/mL, 26.5 ng/mL, 33.9 ng/mL, and 43.6 ng/mL, they said.

The minimal difference in mortality suggests supplements may not be necessary for 3 million adults with chronic kidney disease and 75 million without kidney disease.

After the investigators controlled for risk factors including age, race, sex, smoking status, and comorbid conditions, the all-cause mortality rate was determined for the patients with kidney disease. The mortality rate was 153/1,000 person-years for those with vitamin D levels less than 12 ng/mL, 121/1,000 person-years for those in the 12-to 16-ng/mL group, and 108/1,000 person years for those in the 24- to 29.9ng/mL range.

Mortality rates were similar for those with kidney disease and vitamin D levels greater than 20 ng/mL, with the lowest mortality rate of 97/1,000 person-years seen in those in the highest vitamin D group, Dr. Kramer and her associates reported.

Among the patients without kidney disease, the adjusted all-cause mortality rate was 17/1,000 person-years among those with vitamin D levels less than 12 ng/mL, compared with 13 for those in the 24- to 29.9-ng/mL range and 12 among patients with vitamin D levels greater than 40 ng/mL.

The study was limited by its observational design, and the results may not be generalizable to nursing home residents, individuals on dialysis, or anyone who has had a kidney transplant, the researchers noted.

Vitamin D supplementation has been linked to an increased risk of cancer and kidney stones, and clinical trials are needed to assess the risks versus benefits in individuals with and without kidney disease, the researchers added.

The National Institutes of Health supported the study.

BY HEIDI SPLETE

FROM PLOS ONE
COPYRIGHT 2012 International Medical News Group
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2012 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:DIGESTIVE DISORDERS
Author:Splete, Heidi
Publication:Family Practice News
Article Type:Clinical report
Date:Nov 15, 2012
Words:624
Previous Article:For patients with cholecystitis, discharge should wait.
Next Article:Aspirin best prophylaxis for migraine with aura.
Topics:

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters